About this trial
This randomized clinical trial investigates the effects of modified CIMT with and without the addition of PNF techniques on upper extremity function in pediatric stroke patients, aiming to determine whether combining these approaches yields superior motor recovery.This study will be conducted as a randomized clinical trial over an intervention period of six-week. 20 pediatric stroke patients with upper extremity impairments will be randomly assigned to two groups: one receiving modified CIMT alone and the other receiving modified CIMT combined with PNF techniques. Pre- and post-intervention assessments will be conducted using standardized measures, such as Pediatric Motor Activity Log(PMAL) for upper extremity function, Modified Ashworth Scale(MAS) and Manual Ability Classification System(MACS). Muscle tone and physical activity status will also be evaluated. Data will be entered and analyzed in SPSS V-26.0 to compare improvements in motor function between the two groups, with statistical significance assessed to determine the efficacy of each intervention
Eligibility criteria
Qualifiers
Paeds Patients with confirmed diagnosis of Stroke
Children between age 5 to 13 years
Modified Ashworth Scale spasticity level 1 and 2.
Patients having Manual Ability Classification System Score between 3 to 6.
Disqualifiers
Patients with epilepsy or seizure disorder
Patients with history of botulinum toxin injection, cognitive impairment, fracture and any surgical procedure in upper extremity
Trial design
Treatments tested in this trial
- Modified CIMT
- Proprioceptive Neuromuscular Facilitation